中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

血浆致动脉粥样硬化指数联合急性胰腺炎床旁严重度指数对重症高甘油三酯血症性急性胰腺炎的早期预测价值

戢奇 黄燨 佘琛怡 张松 徐维田 吴清明

引用本文:
Citation:

血浆致动脉粥样硬化指数联合急性胰腺炎床旁严重度指数对重症高甘油三酯血症性急性胰腺炎的早期预测价值

DOI: 10.3969/j.issn.1001-5256.2023.06.021
基金项目: 

国家自然科学基金 (82200708);

湖北省自然科学基金 (2021CFB001)

伦理学声明:本研究方案于2022年10月20日通过中部战区总医院伦理委员会审核批准,批号为[2022]035-01。
利益冲突声明:本文不存在任何利益冲突。
作者贡献声明:戢奇负责课题设计,数据采集,统计分析,论文撰写与修改;黄燨、佘琛怡负责数据采集及分析;徐维田、张松负责研究指导和论文审阅;吴清明负责指导论文撰写及定稿。
详细信息
    通信作者:

    吴清明,wuhe9224@sina.com (ORCID: 0000-0002-8009-1867)

Value of atherogenic index of plasma combined with Bedside Index for Severity in Acute Pancreatitis in the early prediction of severe hypertriglyceridemic acute pancreatitis

Research funding: 

National Natural Science Foundation of China (82200708);

Natural Science Foundation of Hubei Province (2021CFB001)

More Information
  • 摘要:   目的  探讨血浆致动脉粥样硬化指数(AIP)与高甘油三酯血症性急性胰腺炎(HTG-AP)严重程度的相关性,评估AIP及联合急性胰腺炎床旁严重度指数(BISAP)对于重症HTG-AP(sHTG-AP)的早期预测价值。  方法  回顾性分析2017年1月—2021年12月中部战区总医院170例HTG-AP住院患者的临床资料,根据指南分为sHTG-AP组(n=28)和非sHTG-AP组(n=142)。所有患者均于入院24 h内完成外周血采集,比较两组患者性别、年龄、实验室检查结果、AIP、BISAP评分和MCTSI评分等。计数资料组间比较采用χ2检验或Fisher精确概率法。计量资料两组间比较采用Mann-Whitney U检验。采用Spearman秩相关检验分析各因素与HTG-AP严重程度的相关性,二元Logistic回归分析sHTG-AP的独立危险因素。绘制受试者工作特征曲线分析各指标预测效能。  结果  两组患者糖尿病病史、LYM、Alb、Ca2+、TG、HDL-C、AIP、BISAP评分、MCTSI评分、住院天数、住院费用之间均存在统计学差异(P值均<0.05)。sHTG-AP组住院时间更长,住院费用更高,AIP值更大。AIP(OR=1.244,95%CI: 1.062~1.458,P=0.007)、BISAP评分(OR=5.525,95%CI: 1.646~18.543,P=0.006)和MCTSI评分(OR=2.029,95%CI: 1.245~3.305,P=0.004)是sHTG-AP患者的危险因素。AIP、BISAP和MCTSI均与HTG-AP严重程度呈正相关(P值均<0.001),相关系数分别为0.291、0.631、0.649;AIP与BISAP评分、MCTSI评分正相关(P值均<0.05),相关系数分别为0.190、0.215。AIP预测sHTG-AP的最佳截断值为1.095,AIP、BISAP评分及AIP联合BISAP评分的曲线下面积分别为0.759、0.887、0.925,敏感度分别为0.821、0.857、0.786,特异度分别为0.627、0.817、0.937(P值均<0.001)。  结论  AIP是sHTG-AP的危险因素并与疾病严重程度相关,联合BISAP评分对于sHTG-AP具有较高的早期预测价值。

     

  • 图  1  各指标预测sHTG-AP的ROC曲线

    Figure  1.  ROC curve of each index predicting sHTG-AP

    表  1  组间一般临床资料比较

    Table  1.   Comparison of the general clinical data between the two groups

    指标 非sHTG-AP组
    (n=142)
    sHTG-AP组
    (n=28)
    统计值 P
    男性(例) 109 25 χ2=2.198 0.138
    年龄(岁) 37(31~46) 43(35~49) Z=-1.932 0.053
    糖尿病(例) 47 16 χ2=5.797 0.016
    脂肪肝(例) 99 19 χ2=0.038 0.845
    NEUT(×109) 10.16(7.79~11.79) 9.75(7.61~11.56) Z=-0.170 0.865
    LYM(×109) 1.28(0.92~1.76) 0.97(0.72~1.36) Z=-2.830 0.005
    TBil(μmol/L) 17.05(12.35~24.13) 20.25(14.08~27.15) Z=-0.660 0.509
    Alb(g/L) 41(38~44) 39(34~41) Z=-2.903 0.004
    SCr(μmol/L) 53(39~64) 62(40~90) Z=-1.813 0.070
    Ca2+(mmol/L) 2.15(2.09~2.27) 2.10(1.86~2.18) Z=-2.394 0.017
    TC(mmol/L) 8.28(6.27~11.15) 9.05(5.58~12.88) Z=-0.317 0.751
    TG(mmol/L) 11.44(5.35~14.43) 13.79(9.73~19.20) Z=-2.428 0.015
    HDL-C(mmol/L) 1.07(0.75~1.34) 0.70(0.30~1.08) Z=-3.464 0.001
    AIP 1.03(0.70~1.21) 1.22(1.12~1.59) Z=-4.321 <0.001
    BISAP 1(0~1) 2(2~2) Z=-6.854 <0.001
    MCTSI 4(2~6) 6(6~8) Z=-6.987 <0.001
    住院时长(d) 9(7~13) 13(9~23) Z=-3.408 0.001
    费用(元) 14 752(9 881~27 646) 44 608(2 732~66 878) Z=-5.319 <0.001
    下载: 导出CSV

    表  2  二元Logistic回归分析sHTG-AP的危险因素

    Table  2.   Binary logistic regression analysis of risk factors for sHTG-AP

    指标 B OR 95%CI P
    糖尿病 0.287 1.333 0.311~5.707 0.699
    LYM -0.972 0.378 0.090~1.598 0.186
    Alb -0.102 0.903 0.781~1.045 0.172
    Ca2+ 1.521 4.577 0.198~105.820 0.342
    AIP 0.219 1.244 1.062~1.458 0.007
    BISAP 1.709 5.525 1.646~18.543 0.006
    MCTSI 0.707 2.029 1.245~3.305 0.004
    下载: 导出CSV

    表  3  各指标对sHTG-AP的预测效能

    Table  3.   Predictive efficacy of each index for sHTG-AP

    变量 截断值 AUC 95%CI P 敏感度 特异度
    TG 7.040 0.645 0.543~0.748 0.015 0.929 0.331
    HDL-C 0.510 0.707 0.587~0.828 <0.001 0.429 0.944
    AIP 1.095 0.759 0.668~0.850 <0.001 0.821 0.627
    BISAP评分 1.500 0.887 0.832~0.942 <0.001 0.857 0.817
    AIP联合BISAP 2.500 0.925 0.876~0.974 <0.001 0.786 0.937
    下载: 导出CSV
  • [1] PU W, LUO G, CHEN T, et al. A 5-year retrospective cohort study: Epidemiology, etiology, severity, and outcomes of acute pancreatitis[J]. Pancreas, 2020, 49(9): 1161-1167. DOI: 10.1097/MPA.0000000000001637.
    [2] WU H, MA K, LIAO B, et al. Comparative analysis of early clinical features and complications of different types of acute pancreatitis[J]. Oxid Med Cell Longev, 2022, 2022: 3771610. DOI: 10.1155/2022/3771610.
    [3] LIU SZ, YAO JR, MO SJ, et al. Research progress of nutritional support in severe acute pancreatitis[J/OL]. Chin J Hepat Surg(Electronic Edition), 2021, 10(5): 533-535. DOI: 10.3877/cma.j.issn.2095-3232.2021.05.022.

    刘世洲, 姚佳柔, 莫绍剑, 等. 重症急性胰腺炎营养支持研究进展[J/OL]. 中华肝脏外科手术学电子杂志, 2021, 10(5): 533-535. DOI: 10.3877/cma.j.issn.2095-3232.2021.05.022.
    [4] DOBIÁSOVÁ M, FROHLICH J. The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FER(HDL))[J]. Clin Biochem, 2001, 34(7): 583-588. DOI: 10.1016/s0009-9120(01)00263-6.
    [5] CHO SK, KIM JW, HUH JH, et al. Atherogenic index of plasma is a potential biomarker for severe acute pancreatitis: a prospective observational study[J]. J Clin Med, 2020, 9(9): 2982. DOI: 10.3390/jcm9092982.
    [6] WANG Q, WANG G, QIU Z, et al. Elevated serum triglycerides in the prognostic assessment of acute pancreatitis: a systematic review and meta-analysis of observational studies[J]. J Clin Gastroenterol, 2017, 51(7): 586-593. DOI: 10.1097/MCG.0000000000000846.
    [7] SU W, GUO F. Triglyceride-controlling during acute phase of hypertriglyceridemia induced pancreatitis[J]. Chin J Dig Surg, 2023, 22(1): 89-93. DOI: 10.3760/cma.j.cn115610-20221220-00755.

    苏伟, 郭丰. 高甘油三酯血症性胰腺炎急性期的血脂控制[J]. 中华消化外科杂志, 2023, 22(1): 89-93. DOI: 10.3760/cma.j.cn115610-20221220-00755.
    [8] HANSEN S, MADSEN CM, VARBO A, et al. Low-grade inflammation in the association between mild-to-moderate hypertriglyceridemia and risk of acute pancreatitis: a study of more than 115000 individuals from the general population[J]. Clin Chem, 2019, 65(2): 321-332. DOI: 10.1373/clinchem.2018.294926.
    [9] DONG X, PAN S, ZHANG D, et al. Hyperlipemia pancreatitis onset time affects the association between elevated serum triglyceride levels and disease severity[J]. Lipids Health Dis, 2022, 21(1): 49. DOI: 10.1186/s12944-022-01656-4.
    [10] ZHANG Y, GUO F, LI S, et al. Decreased high density lipoprotein cholesterol is an independent predictor for persistent organ failure, pancreatic necrosis and mortality in acute pancreatitis[J]. Sci Rep, 2017, 7(1): 8064. DOI: 10.1038/s41598-017-06618-w.
    [11] LI YJ, LI J. The value of red blood cell distribution width to platelet ratio and C-reactive protein to albumin ratio combined with BISAP scores in the assessment of acute pancreatitis[J]. Chin J Emerg Med, 2022, 31(9): 1200-1205. DOI: 10.3760/cma.j.issn.1671-0282.2022.09.008.

    李艳杰, 李静. 红细胞分布宽度/血小板计数、C反应蛋白/白蛋白联合BISAP评分对急性胰腺炎病情评估的价值[J]. 中华急诊医学杂志, 2022, 31(9): 1200-1205. DOI: 10.3760/cma.j.issn.1671-0282.2022.09.008.
    [12] DONG BY, MAO YQ, LI ZY, et al. The value of the atherogenic index of plasma in non-obese people with non-alcoholic fatty liver disease: a secondary analysis based on a cross-sectional study[J]. Lipids Health Dis, 2020, 19(1): 148. DOI: 10.1186/s12944-020-01319-2.
    [13] LI YW, KAO TW, CHANG PK, et al. Atherogenic index of plasma as predictors for metabolic syndrome, hypertension and diabetes mellitus in Taiwan citizens: a 9-year longitudinal study[J]. Sci Rep, 2021, 11(1): 9900. DOI: 10.1038/s41598-021-89307-z.
    [14] WON KB, HEO R, PARK HB, et al. Atherogenic index of plasma and the risk of rapid progression of coronary atherosclerosis beyond traditional risk factors[J]. Atherosclerosis, 2021, 324: 46-51. DOI: 10.1016/j.atherosclerosis.2021.03.009.
    [15] LI X, GUO X, JI H, et al. Relationships between metabolic comorbidities and occurrence, severity, and outcomes in patients with acute pancreatitis: a narrative review[J]. Biomed Res Int, 2019, 2019: 2645926. DOI: 10.1155/2019/2645926.
    [16] HUANG HM, YANG HY, QIN YY, et al. Relationship between visceral fat related index and the severity of acute pancreatitis[J]. J Clin Hepatol, 2022, 38(10): 2313-2319. DOI: 10.3969/j.issn.1001-5256.2022.10.021.

    黄河铭, 杨慧莹, 覃颖颖, 等. 内脏脂肪相关指数与急性胰腺炎严重程度的关系[J]. 临床肝胆病杂志, 2022, 38(10): 2313-2319. DOI: 10.3969/j.issn.1001-5256.2022.10.021.
    [17] SONG XJ, GAO WB, ZHU JH. The prognostic value of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio combined with BISAP score for severe hypertriglyceridemia pancreatitis[J]. Chin J Emerg Med, 2022, 31(9): 1193-1199. DOI: 10.3760/cma.j.issn.1671-0282.2022.09.007.

    宋小静, 高伟波, 朱继红. 中性粒/淋巴细胞比率、血小板/淋巴细胞比率联合BISAP评分对于重症高三酰甘油血症性胰腺炎早期预测分析[J]. 中华急诊医学杂志, 2022, 31(9): 1193-1199. DOI: 10.3760/cma.j.issn.1671-0282.2022.09.007.
  • 加载中
图(1) / 表(3)
计量
  • 文章访问数:  366
  • HTML全文浏览量:  54
  • PDF下载量:  32
  • 被引次数: 0
出版历程
  • 收稿日期:  2022-10-31
  • 录用日期:  2022-12-05
  • 出版日期:  2023-06-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回